Login / Signup

Q fever - immune responses and novel vaccine strategies.

Patricia ReddenKaitland ParkerSinead HendersonPhillip FourieLinda AgnewJohn StenosStephen GravesBrenda GovanRobert E NortonNatkunam Ketheesan
Published in: Future microbiology (2023)
Q fever is a zoonotic disease caused by the bacterium Coxiella burnetii . It is an occupational risk for employees of animal industries and is associated with contact with wildlife and domestic animals. Although Q fever infection may be asymptomatic, chronic sequelae such as endocarditis occur in 5% of symptomatic individuals. Disease outcomes may be predicted through measurement of immune correlates. Vaccination is the most efficient method to prevent Q fever. Currently, Q-VAX is the only licenced human vaccine. Q-VAX is highly effective; however, individuals previously exposed to C. burnetii are at risk of adverse reactions. This review examines the immunological responses of acute and chronic Q fever and the efforts to provide a safer and cost-effective Q fever vaccine.
Keyphrases
  • immune response
  • endothelial cells
  • liver failure
  • drug induced
  • metabolic syndrome
  • type diabetes
  • intensive care unit
  • hepatitis b virus
  • adipose tissue
  • adverse drug
  • pluripotent stem cells